Skip to content

Another successful Exit from Calculus

Calculus Capital has successfully exited its investors’ shares in Epistem – a personalised medicine and biotechnology company commercialising its expertise in stem cells, infectious disease diagnostics and pharmacogenomics as a guide to therapy selection. Calculus sold the shares in Epistem in May 2014, through a placing in the market, delivering yet another great return to our investors. … Continued

Benito’s Hat appoints New CEO

Benito’s Hat has appointed Richard Baker, formerly of The Restaurant Group as its new chief executive and plans to further strengthen its estate this year following an additional investment of £1.3m from Calculus Capital. Baker joins the six-strong group from Garfunkel’s where he was senior operations manager. He held the same position at TRG Concessions where … Continued